Antibacterial activity of the new glycopeptide antibiotic SKF104662
- 1 April 1989
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 33 (4) , 560-561
- https://doi.org/10.1128/aac.33.4.560
Abstract
The inhibitory activity of the new glycopeptide antibiotic SKF104662 was generally equivalent (+/- 1 concentration increment) to the activities of vancomycin, teicoplanin, and daptomycin against selected gram-positive bacteria. However, SKF104662 demonstrated greater activity against Staphylococcus epidermidis and S. haemolyticus than did teicoplanin and was more active than the other drugs against Clostridium difficile isolates. SKF104662 possessed bactericidal activity quite similar to that of vancomycin against selected isolates of Staphylococcus, Streptococcus, and Enterococcus species.This publication has 5 references indexed in Scilit:
- Antimicrobial activity and spectrum of LY146032, a lipopeptide antibiotic, including susceptibility testing recommendationsAntimicrobial Agents and Chemotherapy, 1987
- In vitro activity of LY146032 (Daptomycin) against selected aerobic bacteriaEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibioticAntimicrobial Agents and Chemotherapy, 1986
- Teicoplanin.1984
- In vitro activity of teichomycin compared with those of other antibioticsAntimicrobial Agents and Chemotherapy, 1983